And another achievement, enhancing medicines accessibility! A.forall, is proud to announce that its U.S. partner, Woodward Pharma Services LLC, has just commercialized its Supplemental Abbreviated New Drug Application (sANDA) approval from the U.S. Food and Drug Administration (FDA) for a generic version of Sodium Acetate Injection 4 mEq/mL marketed by Fresenius Kabi USA LLC. Sodium Acetate Injection, 2 mEq/mL has been commercialized since July 2021 and this newly launched 4 mEq/mL is a more concentrated version that is used to supply sodium in large intravenous (IV) fluids for patients who can’t take fluids by mouth. It’s also an ingredient in custom IV fluid...
News
Launch of a Generic Version of Pyridostigmine Bromide Syrup
We are proud to announce that Milla Pharmaceuticals Inc., an A.forall company, in partnership with Acella Pharmaceuticals LLC, has successfully commercialized its Abbreviated New Drug Application (ANDA) approval from the U.S. Food and Drug Administration (FDA) for a generic version of Mestinon® (Pyridostigmine Bromide Syrup) 60 mg/5mL. Pyridostigmine Bromide Syrup is indicated for the symptomatic treatment of myasthenia gravis, a neuromuscular disorder characterized by muscle weakness and rapid fatigue. A.forall CEO Filip Van de Vliet emphasized the significance of this achievement, stating, “After our rebranding into A.forall, uniting our teams and businesses under one single name that embodies our joint mission of...
Milla Pharmaceuticals Inc. a subsidiary of Alter Pharma Group is Becoming A.forall
The Alter Pharma Group is excited to announce its rebranding, uniting all its brands and businesses. We were already sharing One Mission, and now we also share one brand, one name: A.forall. This change represents an important milestone in A.forall’s pursuit of a world where patients can access high-quality, safe and innovative medicines at an affordable price and strengthens A.forall’s commitment to #MakingAffordableMedicinesAvailableToAll, offering new synergies and ways to leverage the skills and capacities of its 144 employees around the world. “A.forall” is more than a name: it’s a promise – for Accessibility, for Assurance, and for All – a pledge to make healthcare...